Suppr超能文献

(+)-WAY 100135,一种部分激动剂,作用于天然和重组5-HT1B/1D受体。

(+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors.

作者信息

Davidson C, Ho M, Price G W, Jones B J, Stamford J A

机构信息

Anaesthetics Unit (Neurotransmission Laboratory), St Bartholomew's and the Royal London School of Medicine and Dentistry, Royal London Hospital.

出版信息

Br J Pharmacol. 1997 Jun;121(4):737-42. doi: 10.1038/sj.bjp.0701197.

Abstract
  1. We have studied the effects of the purportedly selective 5-HT1A receptor antagonist (+)-WAY 100135 on electrically stimulated 5-hydroxytryptamine (5-HT) efflux in the ventrolateral geniculate nucleus (vLGN), and its affinity at human 5-HT1B and 5-HT1D receptors stably expressed in Chinese hamster ovary (CHO) cells. 2. On short 'pseudo single pulse' stimulations (20 pulses at 100 Hz, 190 ms train duration), (+)-WAY 100135 (1.0 microM) decreased 5-HT efflux in the vLGN to 68 +/- 8% of pre-drug values (P < 0.01). This decrease could be blocked by the 5-HT1D/1B receptor antagonist GR 127935 (50 nM). Conversely, when long stimulations (20 pulses at 20 Hz, 950 ms train) were used, (+)-WAY 100135 had no effect on 5-HT efflux (84 +/- 8% of pre-drug values) although both methiothepin (200 nM) and GR 127935 (50 nM) caused significant increases (to 175 +/- 18 and 130 +/- 10% of pre-drug values, respectively). 3. Paroxetine (100 nM), the selective 5-HT reuptake inhibitor, increased stimulated 5-HT efflux and reuptake half-life (to 145 +/- 18% and 649 +/- 121%, respectively) on pseudo single pulse stimulations. When (+)-WAY 100135 was added in combination with the uptake blocker, the effect of paroxetine on stimulated 5-HT efflux was potentiated to 282 +/- 48% (P < 0.01) without further effect on the 5-HT reuptake half-life. 4. The affinity and intrinsic activity of (+)-WAY 100135 were determined at recombinant human 5-HT1B and 5-HT1D receptors expressed in CHO cells, by use of radioligand binding and [35S]-GTP gamma S binding (+)-WAY 100135 was a partial agonist at human 5-HT1B and 5-HT1D receptors with moderately high affinity for 5-HT1D receptors (pEC50 = 7.61). 5. In conclusion, (+)-WAY 100135 was found to be not a selective 5-HT1A autoreceptor antagonist but may act as a partial agonist at the 5-HT1B/1D receptor, displaying agonist or antagonist properties depending on the stimulation protocol used and the resultant 5-HT 'tone' at the receptor.
摘要
  1. 我们研究了据称具有选择性的5-羟色胺1A(5-HT1A)受体拮抗剂(+)-WAY 100135对腹外侧膝状核(vLGN)中电刺激诱发的5-羟色胺(5-HT)外流的影响,以及它对稳定表达于中国仓鼠卵巢(CHO)细胞中的人5-HT1B和5-HT1D受体的亲和力。2. 在短时间的“伪单脉冲”刺激(100 Hz下20个脉冲,串长190 ms)时,(+)-WAY 100135(1.0 microM)使vLGN中的5-HT外流降至给药前值的68±8%(P<0.01)。这种降低可被5-HT1D/1B受体拮抗剂GR 127935(50 nM)阻断。相反,当使用长时间刺激(20 Hz下20个脉冲,串长950 ms)时,(+)-WAY 100135对5-HT外流无影响(为给药前值的84±8%),尽管甲硫哒嗪(200 nM)和GR 127935(50 nM)均引起显著增加(分别增至给药前值的175±18%和130±10%)。3. 选择性5-羟色胺再摄取抑制剂帕罗西汀(100 nM)在伪单脉冲刺激时增加了刺激诱发的5-HT外流和再摄取半衰期(分别增至145±18%和649±121%)。当(+)-WAY 100135与摄取阻滞剂联合添加时,帕罗西汀对刺激诱发的5-HT外流的作用增强至282±48%(P<0.01),而对5-HT再摄取半衰期无进一步影响。4. 通过放射性配体结合和[35S]-GTPγS结合测定了(+)-WAY 100135在CHO细胞中表达的重组人5-HT1B和5-HT1D受体上的亲和力和内在活性。(+)-WAY 100135是一种人5-HT1B和5-HT1D受体的部分激动剂,对5-HT1D受体具有中等高度的亲和力(pEC50 = 7.61)。5. 总之,发现(+)-WAY 100135并非选择性5-HT1A自身受体拮抗剂,而是可能作为5-HT1B/1D受体的部分激动剂,根据所采用的刺激方案和受体处产生的5-HT“张力”表现出激动剂或拮抗剂特性。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验